Role of stem cells in normal liver and cancer

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 6, 2011, Pages 522-528

  Lau, Chi Keung ^a,b   Yang, Zhen Fan ^a,b   Fan, Sheung Tat ^a,b  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer stem cells; Hepatocellular carcinoma; Normal stem cells

Indexed keywords

BETA CATENIN; BMI1 PROTEIN; CD133 ANTIGEN; CELL MARKER; EPITHELIAL CELL ADHESION MOLECULE; FRIZZLED PROTEIN; HERMES ANTIGEN; INTERLEUKIN 6; MICROSOMAL AMINOPEPTIDASE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; SONIC HEDGEHOG PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX17; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CANCER RADIOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; EMBRYO DEVELOPMENT; GENE DELETION; GENE IDENTIFICATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER REGENERATION; LIVER RESECTION; MOLECULARLY TARGETED THERAPY; NONHUMAN; PROTEIN EXPRESSION; RADIOFREQUENCY ABLATION; REVIEW; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

EID: 79959321260     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011796011091     Document Type: Review

References (98)

1. Bosch, F. X.; Ribes, J.; Cleries, R.; Diaz, M., Epidemiology of hepatocellular carcinoma. Clin. Liver Dis., 2005, 9(2), 191-211, v
2. Bosch, F. X.; Ribes, J.; Diaz, M.; Cleries, R., Primary liver cancer: worldwide incidence and trends. Gastroenterology, 2004, 127(5 Suppl 1), S5-S16
3. El-Serag, H. B.; Davila, J. A.; Petersen, N. J.; McGlynn, K. A., The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann. Intern. Med., 2003, 139 (10), 817-823
4. Sherman, M., Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin. Liver Dis., 2005, 25(2), 143-154.
5. MacSween, R. N. M., Pathology of the liver. 4th ed.; Churchill Livingstone: London; New York, 2002; p xix, 982 p.
6. Llovet, J. M.; Beaugrand, M., Hepatocellular carcinoma: present status and future prospects. J. Hepatol., 2003, 38 Suppl 1, S136-S149.
7. Poon, R. T.; Fan, S. T., Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function. Liver Transpl., 2004, 10(6), 813-815.
8. Llovet, J. M.; Bruix, J., Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology, 2003, 37 (2), 429-442
9. Ng, K. K.; Poon, R. T., Radiofrequency ablation for malignant liver tumor. Surg. Oncol., 2005, 14(1), 41-52.
10. Tateishi, R.; Shiina, S.; Teratani, T.; Obi, S.; Sato, S.; Koike, Y.; Fujishima, T.; Yoshida, H.; Kawabe, T.; Omata, M., Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer, 2005, 103(6), 1201-1209.
11. Lo, C. M.; Ngan, H.; Tso, W. K.; Liu, C. L.; Lam, C. M.; Poon, R. T.; Fan, S. T.; Wong, J., Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology, 2002, 35(5), 1164-1171.
12. Wysocki, P. J., Targeted therapy of hepatocellular cancer. Expert Opin. Investig. Drugs, 2010, 19(2), 265-274.
13. Park, C. Y.; Tseng, D.; Weissman, I. L., Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol. Ther., 2009, 17(2), 219-230.
14. Fausto, N., Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology, 2004, 39(6), 1477-1487
15. Michalopoulos, G. K.; DeFrances, M. C., Liver regeneration. Science, 1997, 276(5309), 60-66.
16. Alison, M. R.; Golding, M.; Sarraf, C. E.; Edwards, R. J.; Lalani, E. N., Liver damage in the rat induces hepatocyte stem cells from biliary epithelial cells. Gastroenterology, 1996, 110(4), 1182-1190
17. Petersen, B. E.; Zajac, V. F.; Michalopoulos, G. K., Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology, 1998, 27(4), 1030-1038.
18. Farber, E., Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylaminofluorene, and 3'-methyl-4-dimethylaminoazobenzene. Cancer Res., 1956, 16(2), 142-148.
19. Theise, N. D.; Saxena, R.; Portmann, B. C.; Thung, S. N.; Yee, H.; Chiriboga, L.; Kumar, A.; Crawford, J. M., The canals of Hering and hepatic stem cells in humans. Hepatology, 1999, 30(6), 1425-1433.
20. Crosby, H. A.; Hubscher, S.; Fabris, L.; Joplin, R.; Sell, S.; Kelly, D.; Strain, A. J., Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am. J. Pathol., 1998, 152(3), 771-779
21. Roskams, T.; De Vos, R.; Van Eyken, P.; Myazaki, H.; Van Damme, B.; Desmet, V., Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J. Hepatol., 1998, 29(3), 455-463
22. Zhou, H.; Rogler, L. E.; Teperman, L.; Morgan, G.; Rogler, C. E., Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology, 2007, 45(3), 716-724.
23. Kim, T. H.; Mars, W. M.; Stolz, D. B.; Petersen, B. E.; Michalopoulos, G. K., Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology, 1997, 26 (4), 896-904
24. Petersen, B. E., Hepatic stem cells: coming full circle. Blood Cells Mol. Dis., 2001, 27(3), 590-600
25. Petersen, B. E.; Bowen, W. C.; Patrene, K. D.; Mars, W. M.; Sullivan, A. K.; Murase, N.; Boggs, S. S.; Greenberger, J. S.; Goff, J. P., Bone marrow as a potential source of hepatic oval cells. Science, 1999, 284 (5417), 1168-1170.
26. Thorgeirsson, S. S.; Grisham, J. W., Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology, 2006, 43(1), 2-8.
27. Lagasse, E.; Connors, H.; Al-Dhalimy, M.; Reitsma, M.; Dohse, M.; Osborne, L.; Wang, X.; Finegold, M.; Weissman, I. L.; Grompe, M., Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med., 2000, 6(11), 1229-1234.
28. Willenbring, H.; Bailey, A. S.; Foster, M.; Akkari, Y.; Dorrell, C.; Olson, S.; Finegold, M.; Fleming, W. H.; Grompe, M., Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat. Med., 2004, 10(7), 744-748.
29. Park, C. H.; Bergsagel, D. E.; McCulloch, E. A., Mouse myeloma tumor stem cells: a primary cell culture assay. J. Natl. Cancer Inst., 1971, 46(2), 411-422.
30. Lobo, N. A.; Shimono, Y.; Qian, D.; Clarke, M. F., The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol., 2007, 23, 675-699.
31. Bonnet, D.; Dick, J. E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med., 1997, 3(7), 730-737
32. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M. A.; Dick, J. E., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 1994, 367(6464), 645-648.
33. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F., Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA, 2003, 100(7), 3983-8988.
34. Hemmati, H. D.; Nakano, I.; Lazareff, J. A.; Masterman-Smith, M.; Geschwind, D. H.; Bronner-Fraser, M.; Kornblum, H. I., Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA, 2003, 100(25), 15178-15183
35. Singh, S. K.; Clarke, I. D.; Terasaki, M.; Bonn, V. E.; Hawkins, C.; Squire, J.; Dirks, P. B., Identification of a cancer stem cell in human brain tumors. Cancer Res., 2003, 63(18), 5821-5828.
36. O'Brien, C. A.; Pollett, A.; Gallinger, S.; Dick, J. E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007, 445(7123), 106-110
37. Ricci-Vitiani, L.; Lombardi, D. G.; Pilozzi, E.; Biffoni, M.; Todaro, M.; Peschle, C.; De Maria, R., Identification and expansion of human coloncancer-initiating cells. Nature, 2007, 445(7123), 111-115.
38. Fang, D.; Nguyen, T. K.; Leishear, K.; Finko, R.; Kulp, A. N.; Hotz, S.; Van Belle, P. A.; Xu, X.; Elder, D. E.; Herlyn, M., A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res., 2005, 65(20), 9328-9337.
39. Li, C.; Heidt, D. G.; Dalerba, P.; Burant, C. F.; Zhang, L.; Adsay, V.; Wicha, M.; Clarke, M. F.; Simeone, D. M., Identification of pancreatic cancer stem cells. Cancer Res., 2007, 67(3), 1030-1037
40. Hermann, P. C.; Huber, S. L.; Herrler, T.; Aicher, A.; Ellwart, J. W.; Guba, M.; Bruns, C. J.; Heeschen, C., Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 2007, 1(3), 313-323.
41. Collins, A. T.; Berry, P. A.; Hyde, C.; Stower, M. J.; Maitland, N. J., Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res., 2005, 65(23), 10946-10951.
42. Prince, M. E.; Sivanandan, R.; Kaczorowski, A.; Wolf, G. T.; Kaplan, M. J.; Dalerba, P.; Weissman, I. L.; Clarke, M. F.; Ailles, L. E., Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 2007, 104(3), 973-978.
43. Alvero, A. B.; Chen, R.; Fu, H. H.; Montagna, M.; Schwartz, P. E.; Rutherford, T.; Silasi, D. A.; Steffensen, K. D.; Waldstrom, M.; Visintin, I.; Mor, G., Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle, 2009, 8(1), 158-166
44. Bapat, S. A.; Mali, A. M.; Koppikar, C. B.; Kurrey, N. K., Stem and progenitorlike cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res., 2005, 65(8), 3025-3029.
45. Eramo, A.; Lotti, F.; Sette, G.; Pilozzi, E.; Biffoni, M.; Di Virgilio, A.; Conticello, C.; Ruco, L.; Peschle, C.; De Maria, R., Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ., 2008, 15(3), 504-514
46. Ho, M. M.; Ng, A. V.; Lam, S.; Hung, J. Y., Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res., 2007, 67 (10), 4827-4833.
47. Fukuda, K.; Saikawa, Y.; Ohashi, M.; Kumagai, K.; Kitajima, M.; Okano, H.; Matsuzaki, Y.; Kitagawa, Y., Tumor initiating potential of side population cells in human gastric cancer. Int. J. Oncol., 2009, 34(5), 1201-1207
48. Takaishi, S.; Okumura, T.; Tu, S.; Wang, S. S.; Shibata, W.; Vigneshwaran, R.; Gordon, S. A.; Shimada, Y.; Wang, T. C., Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells, 2009, 27(5), 1006-1020.
49. Chiba, T.; Kita, K.; Zheng, Y. W.; Yokosuka, O.; Saisho, H.; Iwama, A.; Nakauchi, H.; Taniguchi, H., Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology, 2006, 44(1), 240-251
50. Ma, S.; Chan, K. W.; Hu, L.; Lee, T. K.; Wo, J. Y.; Ng, I. O.; Zheng, B. J.; Guan, X. Y., Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology, 2007, 132(7), 2542-2556
51. Yamashita, T.; Ji, J.; Budhu, A.; Forgues, M.; Yang, W.; Wang, H. Y.; Jia, H.; Ye, Q.; Qin, L. X.; Wauthier, E.; Reid, L. M.; Minato, H.; Honda, M.; Kaneko, S.; Tang, Z. Y.; Wang, X. W., EpCAMpositive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology, 2009, 136(3), 1012-1024
52. Yang, Z. F.; Ho, D. W.; Ng, M. N.; Lau, C. K.; Yu, W. C.; Ngai, P.; Chu, P. W.; Lam, C. T.; Poon, R. T.; Fan, S. T., Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell, 2008, 13(2), 153-166.
53. Song, W.; Li, H.; Tao, K.; Li, R.; Song, Z.; Zhao, Q.; Zhang, F.; Dou, K., Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int. J. Clin. Pract., 2008, 62(8), 1212-1218.
54. Ho, J. W.; Pang, R. W.; Lau, C.; Sun, C. K.; Yu, W. C.; Fan, S. T.; Poon, R. T., Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology, 2006, 44(4), 836-843.
55. Yamashita, T.; Forgues, M.; Wang, W.; Kim, J. W.; Ye, Q.; Jia, H.; Budhu, A.; Zanetti, K. A.; Chen, Y.; Qin, L. X.; Tang, Z. Y.; Wang, X. W., EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res., 2008, 68(5), 1451-1461.
56. Hill, R. P., Identifying cancer stem cells in solid tumors: case not proven. Cancer Res., 2006, 66 (4), 1891-1895; discussion 1890.
57. Haraguchi, N.; Ishii, H.; Mimori, K.; Tanaka, F.; Ohkuma, M.; Kim, H. M.; Akita, H.; Takiuchi, D.; Hatano, H.; Nagano, H.; Barnard, G. F.; Doki, Y.; Mori, M., CD13 is a therapeutic target in human liver cancer stem cells. J. Clin. Invest., 2010, 120(9), 3326-3339.
58. Durnez, A.; Verslype, C.; Nevens, F.; Fevery, J.; Aerts, R.; Pirenne, J.; Lesaffre, E.; Libbrecht, L.; Desmet, V.; Roskams, T., The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology, 2006, 49 (2), 138-1351
59. Wu, P. C.; Lai, V. C.; Fang, J. W.; Gerber, M. A.; Lai, C. L.; Lau, J. Y., Hepatocellular carcinoma expressing both hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells. J. Hepatol., 1999, 31(5), 965-966.
60. Yang, W.; Yan, H. X.; Chen, L.; Liu, Q.; He, Y. Q.; Yu, L. X.; Zhang, S. H.; Huang, D. D.; Tang, L.; Kong, X. N.; Chen, C.; Liu, S. Q.; Wu, M. C.; Wang, H. Y., Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res., 2008, 68(11), 4287-4295.
61. Schwartz, Y. B.; Pirrotta, V., Polycomb silencing mechanisms and the management of genomic programmes. Nat. Rev. Genet., 2007, 8(1), 9-22.
62. Molofsky, A. V.; Pardal, R.; Iwashita, T.; Park, I. K.; Clarke, M. F.; Morrison, S. J., Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature, 2003, 425(6961), 962-967
63. Chiba, T.; Zheng, Y. W.; Kita, K.; Yokosuka, O.; Saisho, H.; Onodera, M.; Miyoshi, H.; Nakano, M.; Zen, Y.; Nakanuma, Y.; Nakauchi, H.; Iwama, A.; Taniguchi, H., Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology, 2007, 133(3), 937-950
64. Iwama, A.; Oguro, H.; Negishi, M.; Kato, Y.; Morita, Y.; Tsukui, H.; Ema, H.; Kamijo, T.; Katoh-Fukui, Y.; Koseki, H.; van Lohuizen, M.; Nakauchi, H., Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity, 2004, 21(6), 843-851.
65. Chiba, T.; Seki, A.; Aoki, R.; Ichikawa, H.; Negishi, M.; Miyagi, S.; Oguro, H.; Saraya, A.; Kamiya, A.; Nakauchi, H.; Yokosuka, O.; Iwama, A., Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice. Hepatology, 2010, 52(3), 1111-1123.
66. Reya, T.; Clevers, H., Wnt signalling in stem cells and cancer. Nature, 2005, 434(7035), 843-850.
67. Yamashita, T.; Budhu, A.; Forgues, M.; Wang, X. W., Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res., 2007, 67 (22), 10831-10839.
68. Ji, J.; Yamashita, T.; Budhu, A.; Forgues, M.; Jia, H. L.; Li, C.; Deng, C.; Wauthier, E.; Reid, L. M.; Ye, Q. H.; Qin, L. X.; Yang, W.; Wang, H. Y.; Tang, Z. Y.; Croce, C. M.; Wang, X. W., Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology, 2009, 50(2), 472-480.
69. Tien, A. C.; Rajan, A.; Bellen, H. J., A Notch updated. J. Cell Biol., 2009, 184 (5), 621-629
70. Androutsellis-Theotokis, A.; Leker, R. R.; Soldner, F.; Hoeppner, D. J.; Ravin, R.; Poser, S. W.; Rueger, M. A.; Bae, S. K.; Kittappa, R.; McKay, R. D., Notch signalling regulates stem cell numbers in vitro and in vivo. Nature, 2006, 442(7104), 823-826.
71. Hoey, T.; Yen, W. C.; Axelrod, F.; Basi, J.; Donigian, L.; Dylla, S.; Fitch-Bruhns, M.; Lazetic, S.; Park, I. K.; Sato, A.; Satyal, S.; Wang, X.; Clarke, M. F.; Lewicki, J.; Gurney, A., DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell, 2009, 5(2), 168-177.
72. Harrison, H.; Farnie, G.; Howell, S. J.; Rock, R. E.; Stylianou, S.; Brennan, K. R.; Bundred, N. J.; Clarke, R. B., Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res., 2010, 70(2), 709-718.
73. Fan, X.; Khaki, L.; Zhu, T. S.; Soules, M. E.; Talsma, C. E.; Gul, N.; Koh, C.; Zhang, J.; Li, Y. M.; Maciaczyk, J.; Nikkhah, G.; Dimeco, F.; Piccirillo, S.; Vescovi, A. L.; Eberhart, C. G., NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells, 2010, 28(1), 5-16.
74. Gramantieri, L.; Giovannini, C.; Lanzi, A.; Chieco, P.; Ravaioli, M.; Venturi, A.; Grazi, G. L.; Bolondi, L., Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. Liver Int., 2007, 27(7), 997-1007.
75. Qi, R.; An, H.; Yu, Y.; Zhang, M.; Liu, S.; Xu, H.; Guo, Z.; Cheng, T.; Cao, X., Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res., 2003, 63(23), 8323-8329.
76. Wang, C.; Qi, R.; Li, N.; Wang, Z.; An, H.; Zhang, Q.; Yu, Y.; Cao, X., Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. J. Biol. Chem., 2009, 284(24), 16183-16190.
77. Maehama, T.; Dixon, J. E., The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 1998, 273(22), 13375-13378.
78. Hu, T. H.; Huang, C. C.; Lin, P. R.; Chang, H. W.; Ger, L. P.; Lin, Y. W.; Changchien, C. S.; Lee, C. M.; Tai, M. H., Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer, 2003, 97(8), 1929-1940.
79. Horie, Y.; Suzuki, A.; Kataoka, E.; Sasaki, T.; Hamada, K.; Sasaki, J.; Mizuno, K.; Hasegawa, G.; Kishimoto, H.; Iizuka, M.; Naito, M.; Enomoto, K.; Watanabe, S.; Mak, T. W.; Nakano, T., Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest., 2004, 113(12), 1774-1783.
80. Rountree, C. B.; Ding, W.; He, L.; Stiles, B., Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells, 2009, 27(2), 290-299.
81. Lee, T. K.; Castilho, A.; Cheung, V. C.; Tang, K. H.; Ma, S.; Ng, I. O., Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation. Hepatology, 2010.
82. Mishra, L.; Derynck, R.; Mishra, B., Transforming growth factorbeta signaling in stem cells and cancer. Science, 2005, 310(5745), 68-71.
83. Tang, Y.; Kitisin, K.; Jogunoori, W.; Li, C.; Deng, C. X.; Mueller, S. C.; Ressom, H. W.; Rashid, A.; He, A. R.; Mendelson, J. S.; Jessup, J. M.; Shetty, K.; Zasloff, M.; Mishra, B.; Reddy, E. P.; Johnson, L.; Mishra, L., Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc. Natl. Acad. Sci. USA, 2008, 105(7), 2445-2450
84. Lin, L.; Amin, R.; Gallicano, G. I.; Glasgow, E.; Jogunoori, W.; Jessup, J. M.; Zasloff, M.; Marshall, J. L.; Shetty, K.; Johnson, L.; Mishra, L.; He, A. R., The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene, 2009, 28(7), 961-972.
85. Laestadius, A.; Soderblom, T.; Aperia, A.; Richter-Dahlfors, A., Developmental aspects of Escherichia coli-induced innate responses in rat renal epithelial cells. Pediatr. Res., 2003, 54(4), 536-541.
86. Ruiz i Altaba, A.; Sanchez, P.; Dahmane, N., Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer, 2002, 2(5), 361-372.
87. Chen, X. L.; Cheng, Q. Y.; She, M. R.; Wang, Q.; Huang, X. H.; Cao, L. Q.; Fu, X. H.; Chen, J. S., Expression of sonic hedgehog signaling components in hepatocellular carcinoma and cyclopamine-induced apoptosis through Bcl-2 downregulation in vitro. Arch. Med. Res., 2010, 41(5), 315-323.
88. Haraguchi, N.; Utsunomiya, T.; Inoue, H.; Tanaka, F.; Mimori, K.; Barnard, G. F.; Mori, M., Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells, 2006, 24(3), 506-513.
89. Wang, X. Q.; Ongkeko, W. M.; Chen, L.; Yang, Z. F.; Lu, P.; Chen, K. K.; Lopez, J. P.; Poon, R. T.; Fan, S. T., Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology, 2010, 52(2), 528-539.
90. Visvader, J. E.; Lindeman, G. J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer, 2008, 8 (10), 755-768
91. Shackleton, M.; Quintana, E.; Fearon, E. R.; Morrison, S. J., Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell, 2009, 138 (5), 822-829.
92. Iliopoulos, D.; Hirsch, H. A.; Wang, G.; Struhl, K., Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc. Natl. Acad. Sci. USA, 2011.
93. Kelly, P. N.; Dakic, A.; Adams, J. M.; Nutt, S. L.; Strasser, A., Tumor growth need not be driven by rare cancer stem cells. Science, 2007, 317(5836), 337
94. Kennedy, J. A.; Barabe, F.; Poeppl, A. G.; Wang, J. C.; Dick, J. E., Comment on Tumor growth need not be driven by rare cancer stem cells. Science, 2007, 318(5857), 1722; author reply 1722.
95. Taussig, D. C.; Miraki-Moud, F.; Anjos-Afonso, F.; Pearce, D. J.; Allen, K.; Ridler, C.; Lillington, D.; Oakervee, H.; Cavenagh, J.; Agrawal, S. G.; Lister, T. A.; Gribben, J. G.; Bonnet, D., Anti CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood, 2008, 112(3), 568-575.
96. Huntly, B. J.; Shigematsu, H.; Deguchi, K.; Lee, B. H.; Mizuno, S.; Duclos, N.; Rowan, R.; Amaral, S.; Curley, D.; Williams, I. R.; Akashi, K.; Gilliland, D. G., MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell, 2004, 6(6), 587-596
97. Yilmaz, O. H.; Valdez, R.; Theisen, B. K.; Guo, W.; Ferguson, D. O.; Wu, H.; Morrison, S. J., Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature, 2006, 441(7092), 475-482.
98. Yang, Z. F.; Ngai, P.; Ho, D. W.; Yu, W. C.; Ng, M. N.; Lau, C. K.; Li, M. L.; Tam, K. H.; Lam, C. T.; Poon, R. T.; Fan, S. T., Identification of local and circulating cancer stem cells in human liver cancer. Hepatology, 2008, 47(3), 919-928.